FUNDAMENTALS
EdgeFII/DII
MANIPALHOSManipal Health Enterprises Limited
₹702.20+0.83%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
MANIPALHOSNSE · EquityHealthcare

Manipal Health Enterprises Limited

ISIN
INE459N01021
Instrument key
NSE_EQ|INE459N01021
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹702.20+5.75 · +0.83%
Day rangecircuit ₹561.80 – ₹842.60
686.10
716.60

as of 21/11/2026, 12:03:44 pm

Open
₹690.00
Day high
₹716.60
Day low
₹686.10
Prev. close
₹696.45
Volume
11.62 L
VWAP
₹708.21

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

5 years · weekly candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M
1Y
5Y
MAX
Change · 5Y
+3.58%
677.95 → 702.20
Period high
₹815.00
24/8/2026
Period low
₹597.00
19/10/2026
From high
-13.84%
+17.62% from low
Avg volume
96.62 L
15.46 Cr total
Volatility · ann.
37.4%
16 candles · 9 up / 7 down
16 Nov 2026O 684.00H 721.60L 661.10C 702.20Vol 76.55 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data16 rows of open, high, low, close and volumeShowHide
16 Nov 2026684.00721.60661.10702.20+2.66%60.5076.55 L
9 Nov 2026660.00693.00652.10681.40+3.24%40.9056.13 L
2 Nov 2026663.50675.10633.25658.40-0.77%41.8551.21 L
26 Oct 2026606.05673.90598.50669.15+10.41%75.4062.65 L
19 Oct 2026642.40644.95597.00607.35-5.46%47.9518.50 L
12 Oct 2026705.00707.05636.25642.40-8.88%70.8028.87 L
5 Oct 2026696.00716.00662.35701.30+0.76%53.6541.63 L
28 Sept 2026725.15760.00683.00696.00-4.02%77.0057.05 L
21 Sept 2026739.00769.75718.95727.50-1.56%50.8045.58 L
14 Sept 2026720.00742.50690.40738.95+2.63%52.1033.22 L

Historical price and volume data · Showing 1–10 of 16

1 / 2

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

105.75
Company
105.75
Sector
39.99

Worse than sector by 164%

P/B

Price ÷ book value per share

5.53
Company
5.53
Sector
4.0

Worse than sector by 38%

ROA

Net income ÷ total assets

3.01%
Company
3.01%
Sector
10.51%

Worse than sector by 71%

ROE

Net income ÷ shareholders' equity

5.84%
Company
5.84%
Sector
17.51%

Worse than sector by 67%

ROCE

EBIT ÷ capital employed

9.8%
Company
9.8%
Sector
18.73%

Worse than sector by 48%

Quick Ratio

Liquid assets ÷ current liabilities

1.17
Company
1.17
Sector
2.72

Worse than sector by 57%

EV/EBITDA

Enterprise value ÷ EBITDA

31.8
Company
31.8
Sector
14.77

Worse than sector by 115%

04/Business

About the company

Sector: Healthcare

Sector market cap (INR)
₹92,366 Cr

reported in crore

Sector market cap (USD)
$10.26B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹10,521 Cr
+25.80% vs Mar 2025
Net profit · Mar 2026
₹917 Cr
-15.26% vs Mar 2025
Operating margin
11.2%
was 14.9%
Revenue CAGR · 4p
28.8%
profit 30.3% · op 27.3%
Filed order
Revenue10,5218,3636,2654,928
Revenue growthreported25.8%33.5%27.1%—
Operating profit1,1781,242745571
Operating profit growthreported-5.2%66.7%30.5%—
Operating marginderived11.2%14.9%11.9%11.6%
Net profit9171,082533414
Net profit growthreported-15.3%102.9%28.7%—
Net marginderived8.7%12.9%8.5%8.4%
EPS — basic₹/share, annual7.719.255.2757.36

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹24,865 Cr
+76.69% YoY
Total liabilities
₹16,066 Cr
Net worth
₹8,799 Cr
Liabilities ÷ assets
64.6%
lower means a lighter balance sheet
Filed order
Total assets24,86514,07210,8197,777
Total liabilities16,0668,0726,7314,411
Net worthderived8,7996,0004,0883,366
Liabilities ÷ assetsderived64.6%57.4%62.2%56.7%
Asset growthderived76.7%30.1%39.1%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets20,75611,2178,7616,189
Current Assets4,1092,8552,0581,588
Total Assets24,86514,07210,8197,777
Current Liabilities3,3621,7951,6571,214
Net Current Asset7471,060401374
Non-Current Liabilities12,7036,2775,0753,197
Equity Capital8,7996,0004,0883,366
Total Equity & Liabilities24,86514,07210,8197,777

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹2,078 Cr
+32.40% YoY
Investing
-₹7,037 Cr
Financing
₹4,954 Cr
Free cash flow
-₹4,958 Cr
operating + investing
Filed order
Operating activities2,0781,5701,3891,149
Operating changereported32.4%13.1%20.8%—
Investing activities-7,037-2,658-870-994
Investing changereported-164.7%-205.4%12.4%—
Financing activities4,954904-250-144
Financing changereported448.0%461.3%-74.3%—
Net cash flowderived-4-18426812
Free cash flowoperating + investing-4,958-1,089518155

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax1,1781,242745586
Income before WC changes2,6652,2351,6441,297
Change in Assets-344-219-93-36
Change in Liabilities179-15713086
Change in WC-165-3763650
Cash flow from Operations2,0781,5701,3891,149
Cash flow from Investing-7,037-2,658-870-994
Cash flow from Financing4,954904-250-144
Total Cash Flow-4-18426812
Cash (Start of the year)2913616857
Cash (End of the year)29929136168

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
72.08%
0.00 pts QoQ
FII
3.51%
-0.14 pts QoQ
DII (other)
2.55%
+0.62 pts QoQ
Mutual funds
4.63%
+1.10 pts QoQ
Retail & others
17.23%
-1.58 pts QoQ
Filed order
Promoters72.1%72.1%81.9%81.4%
FII3.5%3.6%0.0%0.0%
DII (other)2.5%1.9%0.0%0.0%
Mutual funds4.6%3.5%0.0%0.0%
Retail & others17.2%18.8%18.1%18.6%
Promoters — QoQ changepts, derived0.0%-9.8%0.4%—
FII — QoQ changepts, derived-0.1%3.6%0.0%—
DII (other) — QoQ changepts, derived0.6%1.9%0.0%—
Mutual funds — QoQ changepts, derived1.1%3.5%0.0%—
Retail & others — QoQ changepts, derived-1.6%0.7%-0.4%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue10,3368,2426,1724,806
Other Income1851219488
Total Revenue10,5218,3636,2654,894
Total Expenses9,2687,1345,3414,206
Profit Before Tax1,1781,242745586
Tax262161212157
Profit After Tax9171,082533429
EPS - Basic7.719.255.2757.36
EPS - Diluted7.679.255.2557.04

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.